|
Q4 2020
Filed on Feb 09, 2021
|
63,841
|
$6.82 - $10.0
$435K - $638K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
13,357
|
$10.88 - $12.88
$145K - $172K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
6,844
|
$28.36 - $34.31
$194K - $235K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
4,238
|
N/A
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
20,422
|
N/A
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
159
|
N/A
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
2,690
|
N/A
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
10,133
|
$13.67 - $16.95
$139K - $172K
|
|
Zomedica Pharmaceuticals Cor
|
Q4 2020
Filed on Feb 09, 2021
|
44,000
|
N/A
|
|
Invesco Exch Trd Slf Idx Fd
|
Q4 2020
Filed on Feb 09, 2021
|
38,372
|
N/A
|
|
Invesco Exch Trd Slf Idx Fd
|
Q4 2020
Filed on Feb 09, 2021
|
104,302
|
N/A
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
13,327
|
N/A
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
10,049
|
$10.99 - $13.52
$110K - $136K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
10,500
|
$41.29 - $58.85
$434K - $618K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
9,418
|
$33.21 - $34.41
$313K - $324K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
40,000
|
$0.79 - $1.39
$31.6K - $55.6K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
11,428
|
$17.17 - $21.36
$196K - $244K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
31,550
|
N/A
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
11,850
|
$27.14 - $33.7
$322K - $399K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
11,559
|
$6.42 - $7.07
$74.2K - $81.7K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
7,461
|
$28.04 - $50.26
$209K - $375K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
21,887
|
N/A
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
20,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
20,720
|
$30.05 - $41.9
$623K - $868K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
5,982
|
$41.04 - $47.78
$246K - $286K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
23,200
|
N/A
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
4,864
|
N/A
|
|
Perth Mint Physical Gold ETF
|
Q4 2020
Filed on Feb 09, 2021
|
71,316
|
N/A
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
6,973
|
$33.15 - $49.5
$231K - $345K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
38,270
|
$11.01 - $12.62
$421K - $483K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
2,017
|
$87.34 - $106.16
$176K - $214K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
11,534
|
$35.7 - $53.16
$412K - $613K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
12,800
|
$3.76 - $7.96
$48.1K - $102K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
18,701
|
$9.19 - $10.08
$172K - $189K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
11,616
|
$38.13 - $48.82
$443K - $567K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
10,323
|
N/A
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
11,457
|
N/A
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
10,744
|
$8.2 - $10.57
$88.1K - $114K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
14,723
|
$9.35 - $13.17
$138K - $194K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
6,010
|
$30.39 - $41.45
$183K - $249K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
5,886
|
$59.23 - $74.74
$349K - $440K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
2,073
|
$116.33 - $145.83
$241K - $302K
|
|
Allianzgi Dividend Int & Prm
|
Q3 2020
Filed on Nov 03, 2020
|
10,813
|
N/A
|
|
|
Q3 2020
Filed on Nov 03, 2020
|
26,334
|
$11.18 - $17.71
$294K - $466K
|
|
|
Q3 2020
Filed on Nov 03, 2020
|
18,501
|
N/A
|
|
|
Q3 2020
Filed on Nov 03, 2020
|
10,497
|
$9.83 - $12.09
$103K - $127K
|
|
|
Q3 2020
Filed on Nov 03, 2020
|
14,664
|
N/A
|
|
|
Q3 2020
Filed on Nov 03, 2020
|
9,286
|
$24.0 - $26.47
$223K - $246K
|
|
Allianzgi Conv Income Fd Ii
|
Q3 2020
Filed on Nov 03, 2020
|
14,582
|
N/A
|
|
|
Q3 2020
Filed on Nov 03, 2020
|
5,353
|
N/A
|
|